Basics |
Beam Therapeutics Inc.
|
IPO Date: |
February 6, 2020 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$1.67B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$1.59 | 3.49%
|
Avg Daily Range (30 D): |
$0.37 | 2.14%
|
Avg Daily Range (90 D): |
$0.81 | 3.75%
|
Institutional Daily Volume |
Avg Daily Volume: |
.88M |
Avg Daily Volume (30 D): |
1.59M |
Avg Daily Volume (90 D): |
1.9M |
Trade Size |
Avg Trade Size (Sh.): |
58 |
Avg Trade Size (Sh.) (30 D): |
64 |
Avg Trade Size (Sh.) (90 D): |
69 |
Institutional Trades |
Total Inst.Trades: |
2,950 |
Avg Inst. Trade: |
$3.15M |
Avg Inst. Trade (30 D): |
$2.57M |
Avg Inst. Trade (90 D): |
$2.91M |
Avg Inst. Trade Volume: |
.08M |
Avg Inst. Trades (Per Day): |
2 |
Market Closing Trades |
Avg Closing Trade: |
$4.86M |
Avg Closing Trade (30 D): |
$3.76M |
Avg Closing Trade (90 D): |
$5.09M |
Avg Closing Volume: |
131.2K |
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-4.61
|
$-1.24
|
$-1.09
|
Diluted EPS
|
$-4.61
|
$-1.24
|
$-1.09
|
Revenue
|
$ 63.58M
|
$ 7.47M
|
$ 30.07M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -387.34M
|
$ -109.27M
|
$ -90.35M
|
Operating Income / Loss
|
$ -430.72M
|
$ -119.29M
|
$ -100.04M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ 240.22M
|
$ 244.41M
|
$ 53.36M
|
PE Ratio
|
|
|
|
|
|
|